𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Association of ADHD with genetic variants in the 5′-region of the dopamine transporter gene: Evidence for allelic heterogeneity

✍ Scribed by K.J. Brookes; X. Xu; R. Anney; B. Franke; K. Zhou; Wai Chen; T. Banaschewski; J. Buitelaar; R. Ebstein; J. Eisenberg; M. Gill; A. Miranda; R.D. Oades; H. Roeyers; A. Rothenberger; J. Sergeant; E. Sonuga-Barke; H.-C. Steinhausen; E. Taylor; S.V. Faraone; P. Asherson


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
72 KB
Volume
147B
Category
Article
ISSN
1552-4841

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Multiple studies have reported an association between attention deficit hyperactivity disorder (ADHD) and the 10‐repeat allele of a variable number tandem repeat (VNTR) polymorphism in the 3′‐untranslated region (3′UTR) of the dopamine transporter gene (DAT1). Yet, recent meta‐analyses of available data find little or no evidence for this association; although there is strong evidence for heterogeneity between datasets. This pattern of findings could arise for several reasons including the presence of relatively rare risk alleles on common haplotype backgrounds or the functional interaction of two or more loci within the gene. We previously described the importance of a specific haplotype at the 3′ end of DAT1, as well as the identification of associated single nucleotide polymorphisms (SNPs) within or close to 5′ regulatory sequences. In this study we replicate the association of SNPs at the 5′ end of the gene and identify a specific risk haplotype spanning the 5′ and 3′ markers. These findings indicate the presence of at least two loci associated with ADHD within the DAT1 gene and suggest that either additive or interaction effects of these two loci on the risk for ADHD. Overall these data provide further evidence that genetic variants of the dopamine transporter gene confer an increased risk for ADHD. © 2008 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


No evidence for allelic association betw
✍ Williams, H.J.; Bray, N.; Murphy, K.C.; Cardno, A.G.; Jones, L.A.; Owen, M.J. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 7 KB 👁 2 views

Dopamine ␤-hydroxylase (DBH), the enzyme that converts dopamine to norepinepherine, has been proposed as being involved in the aetiology of schizophrenia. Previous work identified a functional polymorphism at nucleotide 910 of the DBH gene that results in a codon change in the mature protein Ala304S

No evidence of association or linkage di
✍ Alda M. Ambrósio; James L. Kennedy; Fabio Macciardi; Cathy Barr; Maria J. Soares 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 1 views

## Abstract Alterations in dopaminergic system have been implicated in the pathophysiology of this disease for many years, and this study was performed to assess the possible involvement of the dopamine D4 receptor (__DRD4__) gene polymorphisms either in the 5′ upstream or in the coding regions, in